Whitehawk Therapeutics (WHWK) Return on Assets (2011 - 2026)

Whitehawk Therapeutics (WHWK) has 16 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.

• Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Assets declined to 0.0% in Q1 2026 per WHWK's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Assets topped out at 0.01% in Q4 2025 and bottomed at 0.01% in Q2 2022.
• The 5-year median for Return on Assets is 0.0% (2022), against an average of 0.0%.
• The widest annual swing landed in 2022, when Return on Assets fell 1 bps; it then grew 1 bps in 2023.
• Tracing WHWK's Return on Assets over 5 years: stood at 0.0% in 2022, then tumbled by 51 bps to 0.0% in 2023, then slumped by 69 bps to 0.01% in 2024, then surged by 169 bps to 0.01% in 2025, then tumbled by 107 bps to 0.0% in 2026.
• Per Business Quant, the three latest WHWK Return on Assets figures stand at 0.0% (Q1 2026), 0.01% (Q4 2025), and 0.0% (Q3 2025).

Peer Comparison